MyCural Therapeutics AB
Developing novel small molecule therapies targeting the MYC oncoprotein.
Oversikt
- 10–19
- Ansatte
- 500–749t SEK
- Omsetning
- 2022
- Grunnlagt
Nøkkelbeslutningstakere
Gunilla Ekström
Board member
Pernilla Sandwall
Board member
Dr. Alina Castell
CEO/Researcher
Ann-Charlotte Rosendahl
Chair of the board
+11 flere kontakter i Funnelfeedr
Beskrivelse
MyCural Therapeutics AB is a life science start-up company focused on advancing high-risk cancer therapies. The organization was founded by cancer researchers affiliated with major Swedish universities, including Karolinska Institutet. Their primary mission is to develop potential candidate drugs th...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559395016401
Beslutningstakere
15 kontakter i FunnelfeedrGunilla Ekström
Board member
Pernilla Sandwall
Board member
Dr. Alina Castell
CEO/Researcher
Ann-Charlotte Rosendahl
Chair of the board
Klas Wiman
Board member
Andre kontakter
Leo Nore
Project coordinator
Estefanía Coral
Communication Coordinator
Teodora Andonova
In-vivo Advisor
Vamsi Mopharti
Scientist-Biophysics
+6 flere kontakter i Funnelfeedr
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Affibody Medical AB
Developing next-generation radiopharmaceuticals using proprietary Affibody platform.
Affibody AB
50–99 ansatteDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
DiaBridge AB
0 ansatteDeveloping breakthrough drugs targeting DNA repair for cancer and inflammation.
ONCOINVENT SOLUTIONS AS
45 ansatteNorwegian biotech transforming cancer care via direct alpha therapy.
Beactica Therapeutics AB
6 ansattePrecision medicine company developing novel therapeutics via targeted protein degradation.
Utforsk mer
Spørsmål om MyCural Therapeutics AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo